Analysis for Northrop Grumman
Analysis summary
Northrop Grumman (NOC) currently has a total score of 73 points, placing it in the strong range. The score is made up of Performance (74), Stability (67) and Trend (80). All three sub-scores are currently above average.
Performance scores 74 points (strong). Key strength: 1Y return at 55.1 %. Even the weakest return is still strong in absolute terms: 3Y return at 55.5 %.
Stability scores 67 points (strong). Best-ranked metric: current drawdown at -0.6 %. Main drag: volatility (365d, annualized) at 28.6 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 80 points (very strong). Key strength: Price is about 12.7 % above SMA50. Even the weakest metric remains solid in absolute terms: trend strength at 0.61. That often means the move is strong, but not perfectly steady.
Overall, the score is shaped most by Trend; Stability trails and dampens the total. On a metric level, current drawdown stands out, while volatility (365d, annualized) is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Performance
Stability
FAQ
- What investor type does Northrop Grumman fit best in FoxScore?
- Northrop Grumman fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
- How meaningful is the available history for Northrop Grumman?
- Northrop Grumman currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.